| Literature DB >> 34106907 |
Monica Daibert-Nido1, Yulia Pyatova1, Kyle G Cheung2, Arun Reginald3,4, Eduardo Garcia-Giler2,5, Eric Bouffet4, Samuel N Markowitz1,2, Michael Reber2,6,5,7.
Abstract
BACKGROUND Homonymous hemianopia is a loss of conscious vision in one hemifield, strongly affecting everyday life. Audiovisual stimulation programs improve visual perception in the blind hemifield; however, they use large equipment operated in clinical settings. Such treatments require frequent visits at the clinic, hampering the patient's adherence and compliance. In one hemianopia patient, we tested a 4-week dynamic audiovisual rehabilitation program in the stand-alone, remotely controlled, virtual-reality, head-mounted display Oculus Go and measured the effect on visual perception. CASE REPORT A 15-year-old Caucasian male was diagnosed with a right homonymous hemianopia with splitting of central fixation after a traumatic occipital contusion at age 7 months. Visual assessment showed impaired binocular contrast sensitivity and retinal sensitivity. Fixation stability and visual fields were strongly affected. After a 4-week audiovisual rehabilitation program, including 3 hours 20 minutes of stimulation, the contrast sensitivity, fixation stability, and paracentral visual perception were significantly enhanced, improving quality of life. CONCLUSIONS This pioneering work reports the use of virtual-reality in a head-mounted display to provide an audiovisual stimulation protocol for low-vision rehabilitation in a hemianopia patient. Real-time data recording and remote control of the stimulation program demonstrate that such rehabilitation treatment can be performed by the patient at home without interruption of care, decreasing the burden of disease. Beneficial effects on visual function were measured according to clinical guidelines of low-vision assessment. Improvement in visual function and quality of life challenge the prevailing belief that post-acute vision loss is both permanent and unchangeable.Entities:
Mesh:
Year: 2021 PMID: 34106907 PMCID: PMC8202419 DOI: 10.12659/AJCR.931079
Source DB: PubMed Journal: Am J Case Rep ISSN: 1941-5923
Outcome measures at baseline and after treatment.
| Paracentral retinal sensitivity 20 points (dB) | 13.75 | 14 | 18.45 | 14.4 | ±2.31 |
| Bivariate Contour Ellipse Area 68% (BCEA, °2) | 31.02 | 2.18 | 0.59 | 0.61 | ±0.61 |
| Humphrey Full-Field (# points seen) | 47/81 (58.0%) | 46/81 (56.8%) | 50/81 (61.7%) | 43/81 (53.1%) | ±3 adjacent points |
| Quality of life (orientation and mobility – logits) | 2.39 | 3.01 | ±0.44 | ||
OD – oculus dexter – right eye; OS – oculus sinister – left eye; BCEA – bivariate contour ellipse area; COR – coefficient of repeatability.